Monthly Archives: October 2010
A Victoria Woman Living With a Spinal Cord Injury Is Going to Cycle India Covering More Than 3-Thousand Kilometres Pushing a Hand-Cycle.
A patient paralysed through spinal cord injury has become the first person to receive human embryonic stem (ES) cell treatment in a clinical trial being conducted in the United States. The anonymous patient was injected with stem cells at the site of injury in the hope that the cells will repair the damaged nerve tissue to restore some movement.
Rutgers defense tackle Eric LeGrand currently has no movement below the neck following surgery Saturday night for a spinal cord injury he suffered in the Scarlet Knights’ 23-20 overtime victory at Army.
HOUSTON (KTRK) — Three years ago, a hit on the football field left Kevin Everett paralyzed. He became one of the 300,000 Americans living with spinal cord injuries.
Everett has recovered from his injury, and he credits his faith, rehab and something rarely done for spinal cord injury: cooling.
In 2007, Everett’s promising career with the Buffalo Bills came to an end with one hit.
NEW YORK — Geron Corp. has begun testing an embryonic stem-cell treatment on a patient with spinal cord injuries, marking the first time such a drug has been used on a human.
The company said it enrolled the first patient in the early stage study, which will look at the safety of the treatment and how well the patient can tolerate it. The patient was enrolled at Shepherd Center, a spinal cord and brain injury rehabilitation center in Atlanta, one of seven potential sites in the United States. In order to participate, the patient must have been injured within the last two weeks.
Oct. 11 (Bloomberg) — Geron Corp. used a therapy made from stem cells taken from human embryos to treat a patient paralyzed by a spinal-cord injury in the first U.S.-authorized test of the technology.
The patient was treated Oct. 8 at Shepherd Center, a rehabilitation hospital in Atlanta, the company said today in a statement. The study is designed to test the safety of Geron’s therapy in patients with spinal cord injuries. The U.S. Food and Drug Administration gave permission in July for Geron to start the study after a halt of almost a year over safety concerns.
Imagine the plight of a young person, the sole bread-earner in the family, getting paralysed below the neck as a result of a road accident, with no movement or sensation in all four limbs and no control over his bowel and bladder. This poses a big physical, psychological and economic challenge not only for the individual but also for the whole family.
When he was 19, a cliff-diving accident left Dan Cummings of Hyde Park paralyzed from the neck down, and doctors told him that he’d be in a wheelchair for the rest of his life. Yesterday, 10 years after that diagnosis, he walked a mile.
“The years came and went, but I knew as long as I took it one day at time and gave it my all, I would walk again,” Cummings said. “I’ve come a long way,”
Researchers at Karolinska Institutet have shown how stem cells, together with other cells, repair damaged tissue in the mouse spinal cord. The results are of potential significance to the development of therapies for spinal cord injury.
There is hope that damage to the spinal cord and brain will one day be treatable using stem cells (i.e. immature cells that can develop into different cell types). Stem cell-like cells have been found in most parts of the adult human nervous system, although it is still unclear how much they contribute to the formation of new, functioning cells in adult individuals.
On Oct. 7, 2010, Berkeley Bionics unveiled eLEGS, an exoskeleton for wheelchair users who are committed to living life to its fullest. It powers you up to get you standing and walking.